Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?
作者信息
Kim J E, Lee H, Paik S S, Moon J-Y, Yoon H J, Kim S-H
机构信息
Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
出版信息
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e711-e714. doi: 10.1111/jdv.17476. Epub 2021 Jul 12.
Abstract
摘要
相似文献
1
Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?ChAdOx1 nCoV-19疫苗的迟发性皮肤反应：它是“阿斯利康臂”吗？
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e711-e714. doi: 10.1111/jdv.17476. Epub 2021 Jul 12.
2
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.接种ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生的自身免疫性肝炎。
J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.
3
Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.接种ChAdOx1新型冠状病毒疫苗（牛津-阿斯利康/科维希德）后银屑病发作/病情加重：两例报告。
Dermatol Ther. 2021 Sep;34(5):e15085. doi: 10.1111/dth.15085. Epub 2021 Aug 10.
4
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）接种后发生急性脱髓鞘性多发神经根神经病伴双侧面瘫 1 例。
Neurol Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.
5
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.接种 SARS-CoV-2 疫苗后的皮肤反应：一项对 405 例病例的西班牙全国性横断面研究。
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
6
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.牛津大学-阿斯利康ChAdOx1新冠疫苗不会改变血小板聚集。
Semin Thromb Hemost. 2022 Feb;48(1):109-111. doi: 10.1055/s-0041-1728831. Epub 2021 May 10.
7
A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）接种后暴发性心肌炎行心脏移植 1 例
J Korean Med Sci. 2022 Apr 4;37(13):e104. doi: 10.3346/jkms.2022.37.e104.
8
Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.接种 SARS-CoV-2 疫苗后的脑静脉窦血栓形成：向欧洲药品管理局报告的病例分析。
Eur J Neurol. 2021 Nov;28(11):3656-3662. doi: 10.1111/ene.15029. Epub 2021 Aug 4.
9
Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine.首次接种ChAdOx1 nCoV-19疫苗后的局部延迟反应。
Allergy. 2021 Nov;76(11):3520-3522. doi: 10.1111/all.14978. Epub 2021 Jun 26.
10
Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine.阿斯利康新冠疫苗诱发的大疱性类天疱疮。
Ann Dermatol Venereol. 2022 Mar;149(1):56-57. doi: 10.1016/j.annder.2021.07.008. Epub 2021 Sep 30.
引用本文的文献
1
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.基于腺病毒的新冠疫苗中交叉反应性T细胞应答的鉴定
NPJ Vaccines. 2024 Jun 5;9(1):99. doi: 10.1038/s41541-024-00895-z.
2
Two Cases of Delayed Bullous Local Reactions to the ChAdOx1 Adenovirus Vector Vaccine against SARS-CoV-2.两例针对严重急性呼吸综合征冠状病毒2的ChAdOx1腺病毒载体疫苗延迟大疱性局部反应
Ann Dermatol. 2023 Nov;35(Suppl 2):S366-S368. doi: 10.5021/ad.21.227.
3
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
4
Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?阿斯利康新冠疫苗在一名母乳喂养女婴中引起的迟发性皮肤不良反应：巧合还是罕见效应？
Vaccines (Basel). 2022 Apr 13;10(4):602. doi: 10.3390/vaccines10040602.
5
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.SARS-CoV-2 疫苗相关皮肤表现：系统综述。
Int J Dermatol. 2022 Oct;61(10):1187-1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.
6
Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines.19例COVID-19疫苗接种后皮肤不良反应患者的单中心临床病理病例研究
Dermatopathology (Basel). 2021 Sep 27;8(4):463-476. doi: 10.3390/dermatopathology8040049.
7
Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine.接种第一剂ChAdOx1-S新型冠状病毒疫苗后出现结节性红斑。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e161-e162. doi: 10.1111/jdv.17762. Epub 2021 Oct 30.
8
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.新型冠状病毒肺炎疫苗的皮肤不良反应：免疫皮肤病学视角的见解
Vaccines (Basel). 2021 Aug 25;9(9):944. doi: 10.3390/vaccines9090944.
9
Flagellate purpura associated with COVID-19 vaccination.与新冠病毒疫苗接种相关的鞭毛虫性紫癜
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e33-e34. doi: 10.1111/jdv.17609. Epub 2021 Sep 9.
10
Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.与 COVID-19 疫苗接种相关的对称性药物相关性间擦疹和屈侧疹样发疹。
Clin Exp Dermatol. 2022 Jan;47(1):175-176. doi: 10.1111/ced.14898. Epub 2021 Aug 31.
本文引用的文献
1
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.mRNA新冠疫苗接种后的皮肤不良反应：来自意大利东北部的早期报告。
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e548-e551. doi: 10.1111/jdv.17343. Epub 2021 Jun 7.
2
Delayed Large Local Reactions to mRNA Vaccines.mRNA疫苗的延迟性局部大反应
N Engl J Med. 2021 Jun 17;384(24):e98. doi: 10.1056/NEJMc2104751. Epub 2021 Apr 21.
3
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
4
Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.医疗工作者中BNT162b2 mRNA新冠疫苗的皮肤表现。“新冠疫苗接种臂”：临床和组织学特征
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e425-e427. doi: 10.1111/jdv.17250. Epub 2021 Apr 19.
5
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.对SARS-CoV-2的mRNA-1273疫苗的迟发性局部大反应
N Engl J Med. 2021 Apr 1;384(13):1273-1277. doi: 10.1056/NEJMc2102131. Epub 2021 Mar 3.
6
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
Zotero 插件